ValuEngine lowered shares of Cyanotech Corporation (NASDAQ:CYAN) from a hold rating to a sell rating in a research report report published on Friday morning.

Separately, TheStreet raised Cyanotech Corporation from a d rating to a c- rating in a research note on Monday, August 28th.

Shares of Cyanotech Corporation (CYAN) remained flat at $3.95 on Friday. The stock had a trading volume of 913 shares. Cyanotech Corporation has a 12 month low of $3.25 and a 12 month high of $5.35. The firm’s market cap is $22.46 million. The stock has a 50-day moving average price of $4.46 and a 200-day moving average price of $3.89.

Cyanotech Corporation (NASDAQ:CYAN) last announced its quarterly earnings results on Thursday, August 10th. The biotechnology company reported $0.09 EPS for the quarter. The company had revenue of $8.81 million during the quarter. Cyanotech Corporation had a negative return on equity of 0.14% and a negative net margin of 0.07%. Analysts anticipate that Cyanotech Corporation will post ($0.01) earnings per share for the current year.

ILLEGAL ACTIVITY NOTICE: This piece of content was first reported by Watch List News and is owned by of Watch List News. If you are reading this piece of content on another publication, it was copied illegally and reposted in violation of U.S. and international trademark & copyright laws. The correct version of this piece of content can be accessed at

Cyanotech Corporation Company Profile

Cyanotech Corporation is engaged in the production of natural products derived from microalgae for the nutritional supplements market. The Company’s products include Hawaiian Spirulina Pacifica and Hawaiian BioAstin. Hawaiian Spirulina Pacifica is a dietary supplement used for extra energy, a strengthened immune system, cardiovascular benefits and as a source of antioxidant carotenoids.

Receive News & Ratings for Cyanotech Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cyanotech Corporation and related companies with Analyst Ratings Network's FREE daily email newsletter.